PTGS2 and pulmonary fibrosis: In bleomycin-induced pulmonary fibrosis, melatonin reduces the infiltration and accumulation of inflammatory cells in the alveolar walls (111), as well as the expression of inflammatory mediators such as cyclooxygenase 2 (COX-2) (78).